PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia

被引:234
|
作者
Martens, Joost H. A. [1 ]
Brinkman, Arie B. [1 ]
Simmer, Femke [1 ]
Francoijs, Kees-Jan [1 ]
Nebbioso, Angela [2 ]
Ferrara, Felicetto [3 ]
Altucci, Lucia [2 ]
Stunnenberg, Hendrik G. [1 ]
机构
[1] Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy
[3] Osped Antonio Cardarelli, I-80131 Naples, Italy
关键词
ACID-INDUCED DIFFERENTIATION; RETINOIC ACID; HISTONE DEACETYLASE; DNA METHYLATION; CELL-DIFFERENTIATION; GENE-EXPRESSION; FUSION PROTEINS; RXR; COMPLEX; BINDING;
D O I
10.1016/j.ccr.2009.12.042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many different molecular mechanisms have been associated with PML-RAR alpha-dependent transformation of hematopoietic progenitors. Here, we identified high confidence PML-RAR alpha binding sites in an acute promyelocytic leukemia (APL) cell line and in two APL primary blasts. We found colocalization of PML-RAR alpha with RXR to the vast majority of these binding regions. Genome-wide epigenetic studies revealed that treatment with pharmacological doses of all-trans retinoic acid induces changes in H3 acetylation, but not H3K27me3, H3K9me3, or DNA methylation at the PML-RAR alpha/RXR binding sites or at nearby target genes. Our results suggest that PML-RAR alpha/RXR functions as a local chromatin modulator and that specific recruitment of histone deacetylase activities to genes important for hematopoietic differentiation, RAR signaling, and epigenetic control is crucial to its transforming potential.
引用
收藏
页码:173 / 185
页数:13
相关论文
共 50 条
  • [1] Monitoring PML-RARα in acute promyelocytic leukemia
    Joseph G. Jurcic
    Current Oncology Reports, 2003, 5 (5) : 391 - 398
  • [2] PML-RAR, A FUSION PROTEIN IN ACUTE PROMYELOCYTIC LEUKEMIA
    KAKIZUKA, A
    EVANS, RM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 214 - 214
  • [3] Acute promyelocytic leukemia:: Mechanisms of PML-RARα action
    Reineke, EL
    Liu, H
    Liu, Y
    Kao, HY
    FASEB JOURNAL, 2006, 20 (05): : A966 - A966
  • [4] PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia
    Zhu, Hong-Hu
    Wu, Congying
    Sun, Yujie
    Hu, Jiong
    BLOOD, 2018, 132
  • [5] Acute promyelocytic leukemia with amplification of PML-RARα rearrangement: Clinical implications
    Luatti, Simona
    Marzocchi, Giulia
    Ottaviani, Emanuela
    Baldazzi, Carmen
    Stacchini, Monica
    Gamberini, Carla
    Salmi, Federica
    Martinelli, Giovanni
    Baccarani, Michele
    Testoni, Nicoletta
    LEUKEMIA RESEARCH, 2008, 32 (12) : 1941 - 1943
  • [6] Coexistence of PML-RARα and BCR-ABL in acute promyelocytic leukemia
    Pettijohn, Erin M.
    Platanias, Leonidas C.
    Altman, Jessica K.
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 238 - 239
  • [7] The PML-RARα fusion protein and targeted therapy for acute promyelocytic leukemia
    Jing, YK
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 639 - 648
  • [8] C/EBP is deregulated by PML-RAR in acute promyelocytic leukemia.
    Guibal, F
    Radomska, HS
    Johansen, LM
    Tenen, DG
    BLOOD, 2005, 106 (11) : 844A - 845A
  • [9] A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia
    Pollock, JL
    Westervelt, P
    Kurichety, AK
    Pelicci, PG
    Grisolano, JL
    Ley, TJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15103 - 15108
  • [10] PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia
    Li, Ke
    Wang, Feng
    Yang, Zhao-Na
    Cui, Bing
    Li, Ping-Ping
    Li, Zhen-Yu
    Hu, Zhuo-Wei
    Zhu, Hong-Hu
    THERANOSTICS, 2020, 10 (22): : 10326 - 10340